insights_auto
Why is SABS up 2,31%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
3,10 USD
arrow_upward
+2,31%(+0,070) 1D
3,09 USD
arrow_downward
-0,33% (-0,010)bedtimeAfter hours
Closed: 9-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
3,10 USD
High
3,18 USD
Low
3,05 USD
Mkt. cap
282,06 млн
Avg. vol.
642,58 миң
Volume
0,00
52-wk high
5,15 USD
52-wk low
2,44 USD
EPS
-0,63 USD
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
Open
3,10 USD
High
3,18 USD
Low
3,05 USD
Mkt. cap
282,06 млн
Avg. vol.
642,58 миң
Volume
0,00
52-wk high
5,15 USD
52-wk low
2,44 USD
EPS
-0,63 USD
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
News stories
From web sources and news partners
The Motley Fool
·
32 мүнөт мурун
Stock Market Sell-Off: Meet the Unstoppable Vanguard ETF Obliterating the S&P 500 in 2026
Benzinga
·
38 мүнөт мурун
Stock Market Today: Dow, S&P 500 Futures Rise, Nasdaq 100 Futures Fall as Trump Signals Iran War to End
The Motley Fool
·
1 саат мурун
2 Vanguard Index Funds to Buy Now to Beat the S&P 500 in the Next Year, According to Wall Street
FXStreet
·
1 саат мурун
S&P 500: Tech rebound drives strong gains – Deutsche Bank
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersМайами Бич, Флорида, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitesab.bio